March 23, 2026

Can Shorter TB Prevention Regimens Work?

Randomized study evaluates efficacy, safety, and completion in high-risk patients

Conexiant

March 23, 2026

Researchers Propose TMD Definition for GBD

Consensus description may support inclusion in Global Burden of Disease estimates.

Conexiant

March 23, 2026

Collagen Linked to Skin, Joint Benefits

A large umbrella review of randomized trials found the strongest evidence for improvements in skin elasticity and osteoarthritis symptoms.

Conexiant

March 23, 2026

Fibromyalgia Drugs Tested for Value

Investigators compare common fibromyalgia therapies.

Conexiant

March 19, 2026

Lab Markers May Guide Lupus Biologic Use

Analysis of 31 trials links serologic activity and disease severity to improved response.

Conexiant

March 19, 2026

Lumbar Fusion: Two Decades of Change

Investigators find rising use of complex lumbar fusion procedures and increasing hospital costs in the US.

Conexiant

March 18, 2026

FDA Approves New Oral Option for Plaque Psoriasis

Phase 3 data showed high skin clearance rates and adverse event rates similar to placebo through week 16 with once-daily icotrokinra.

Conexiant

March 17, 2026

Vitamin D Deficiency and Bone Disease

Review finds limited evidence that common vitamin D deficiency cutoffs consistently reflect bone disease risk in community dwellers

Conexiant

March 17, 2026

Obesity Medications Get New Guidance

Panel outlines pharmacotherapy roles across obesity complications and long-term weight management.

Conexiant

March 17, 2026

The Missing Step in Pediatric Lupus Care

Survey data show gaps between rheumatologists’ beliefs and clinical practice in screening and neuropsychological evaluation for childhood-onset systemic lupus erythematosus

Conexiant